Recombinant ANGPTL3 (Evinacumab Biosimilar) antibody

Catalog No. ABIN7581247

The Human Monoclonal anti-ANGPTL3 (Evinacumab Biosimilar) antibody has been validated for ELISA, BLI, FACS, Func and SPR. It is suitable to detect ANGPTL3 (Evinacumab Biosimilar) in samples from Human.

Quick Overview for Recombinant ANGPTL3 (Evinacumab Biosimilar) antibody (ABIN7581247)

Target: ANGPTL3 (Evinacumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ANGPTL3 (Evinacumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-ANGPTL3 (Evinacumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-ANGPTL3 Reference Antibody (evinacumab)

Characteristics: Anti-ANGPTL3 Reference Antibody (evinacumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for ANGPTL3 (Evinacumab Biosimilar)

Target: ANGPTL3 (Evinacumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q9Y5C1